CGC three-lens brief
Evidence-based stock research on CGC. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 8.9pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Outperforming SPY by 8.9pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Negative free cash flow last quarterly (-$25.98M).
- Debt-to-equity of 33.6 — balance-sheet-heavy.
CGC closed at $1.14 (+0.44%) as of 2026-05-04. Market cap: $509.71M. Positives: outperforming SPY by 8.9pp over 30 days.. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$25.98M).. Last quarter: Revenue $74.54M, net income -$62.63M, free cash flow -$25.98M.
Why three lenses on CGC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CGCacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CGC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CGC brief"></iframe>